340B Mega-Guidance Won't Stop 'Double Dipping,' Pharma Firms Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Duplicate Medicaid/340B discounts likely won't decrease with HRSA's lack of specific instructions for providers and complex system to opt in/out of providing 340B drugs to Medicaid patients, PhRMA and BIO agree. Bank ID numbers could be one way to track payers.